Raymond James & Associates’s SPDR S&P Pharmaceuticals ETF XPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $337K | Buy |
7,602
+373
| +5% | +$16.5K | ﹤0.01% | 3317 |
|
|
2024
Q2 | $288K | Buy |
7,229
+912
| +14% | +$36.3K | ﹤0.01% | 3367 |
|
|
2024
Q1 | $272K | Buy |
6,317
+134
| +2% | +$5.78K | ﹤0.01% | 3397 |
|
|
2023
Q4 | $257K | Sell |
6,183
-6,393
| -51% | -$266K | ﹤0.01% | 3353 |
|
|
2023
Q3 | $500K | Buy |
12,576
+2,863
| +29% | +$114K | ﹤0.01% | 2878 |
|
|
2023
Q2 | $398K | Buy |
9,713
+2,394
| +33% | +$98.1K | ﹤0.01% | 3051 |
|
|
2023
Q1 | $300K | Buy |
7,319
+282
| +4% | +$11.6K | ﹤0.01% | 3215 |
|
|
2022
Q4 | $288K | Buy |
7,037
+1,520
| +28% | +$62.2K | ﹤0.01% | 3222 |
|
|
2022
Q3 | $222K | Buy |
+5,517
| New | +$222K | ﹤0.01% | 3362 |
|
|
2022
Q2 | – | Sell |
-7,526
| Closed | -$341K | – | 4035 |
|
|
2022
Q1 | $341K | Sell |
7,526
-2,348
| -24% | -$106K | ﹤0.01% | 3310 |
|
|
2021
Q4 | $456K | Sell |
9,874
-1,328
| -12% | -$61.3K | ﹤0.01% | 3141 |
|
|
2021
Q3 | $531K | Buy |
11,202
+374
| +3% | +$17.7K | ﹤0.01% | 3010 |
|
|
2021
Q2 | $561K | Sell |
10,828
-197
| -2% | -$10.2K | ﹤0.01% | 2995 |
|
|
2021
Q1 | $555K | Sell |
11,025
-2,133
| -16% | -$107K | ﹤0.01% | 2931 |
|
|
2020
Q4 | $685K | Sell |
13,158
-5,099
| -28% | -$265K | ﹤0.01% | 2580 |
|
|
2020
Q3 | $794K | Sell |
18,257
-579
| -3% | -$25.2K | ﹤0.01% | 2308 |
|
|
2020
Q2 | $810K | Buy |
+18,836
| New | +$810K | ﹤0.01% | 2293 |
|
|
2020
Q1 | – | Sell |
-38,470
| Closed | -$1.76M | – | 3609 |
|
|
2019
Q4 | $1.76M | Sell |
38,470
-725
| -2% | -$33.1K | ﹤0.01% | 1902 |
|
|
2019
Q3 | $1.4M | Buy |
39,195
+32,449
| +481% | +$1.15M | ﹤0.01% | 1984 |
|
|
2019
Q2 | $269K | Sell |
6,746
-41,020
| -86% | -$1.64M | ﹤0.01% | 3054 |
|
|
2019
Q1 | $1.99M | Sell |
47,766
-16,788
| -26% | -$698K | ﹤0.01% | 1762 |
|
|
2018
Q4 | $2.36M | Sell |
64,554
-5,181
| -7% | -$190K | ﹤0.01% | 1546 |
|
|
2018
Q3 | $3.39M | Buy |
69,735
+2,293
| +3% | +$111K | 0.01% | 1464 |
|
|
2018
Q2 | $2.9M | Sell |
67,442
-520
| -0.8% | -$22.4K | ﹤0.01% | 1536 |
|
|
2018
Q1 | $2.85M | Sell |
67,962
-23,947
| -26% | -$1M | 0.01% | 1479 |
|
|
2017
Q4 | $4M | Buy |
91,909
+49,976
| +119% | +$2.17M | 0.01% | 1251 |
|
|
2017
Q3 | $1.78M | Sell |
41,933
-25,693
| -38% | -$1.09M | ﹤0.01% | 1719 |
|
|
2017
Q2 | $2.91M | Sell |
67,626
-9,055
| -12% | -$390K | 0.01% | 1342 |
|
|
2017
Q1 | $3.21M | Buy |
76,681
+23,145
| +43% | +$968K | 0.01% | 1247 |
|
|
2016
Q4 | $2.09M | Buy |
53,536
+5,849
| +12% | +$229K | 0.01% | 1463 |
|
|
2016
Q3 | $2.11M | Sell |
47,687
-4,172
| -8% | -$184K | 0.01% | 1419 |
|
|
2016
Q2 | $2.17M | Sell |
51,859
-6,665
| -11% | -$279K | 0.01% | 1283 |
|
|
2016
Q1 | $2.36M | Sell |
58,524
-11,025
| -16% | -$444K | 0.01% | 1194 |
|
|
2015
Q4 | $3.56M | Sell |
69,549
-19,575
| -22% | -$1M | 0.01% | 970 |
|
|
2015
Q3 | $4.18M | Sell |
89,124
-24,932
| -22% | -$1.17M | 0.02% | 831 |
|
|
2015
Q2 | $7.11M | Sell |
114,056
-4,756
| -4% | -$297K | 0.03% | 655 |
|
|
2015
Q1 | $7.34M | Sell |
118,812
-5,014
| -4% | -$310K | 0.03% | 573 |
|
|
2014
Q4 | $6.68M | Sell |
123,826
-4,996
| -4% | -$270K | 0.03% | 554 |
|
|
2014
Q3 | $6.83M | Buy |
128,822
+556
| +0.4% | +$29.5K | 0.04% | 489 |
|
|
2014
Q2 | $6.66M | Buy |
128,266
+8,470
| +7% | +$440K | 0.04% | 501 |
|
|
2014
Q1 | $5.61M | Sell |
119,796
-89,056
| -43% | -$4.17M | 0.04% | 535 |
|
|
2013
Q4 | $9.19M | Sell |
208,852
-2,780
| -1% | -$122K | 0.07% | 323 |
|
|
2013
Q3 | $8.15M | Sell |
211,632
-9,352
| -4% | -$360K | 0.07% | 325 |
|
|
2013
Q2 | $7.79M | Buy |
+220,984
| New | +$7.79M | 0.07% | 306 |
|